Prescient Therapeutics (ASX:PTX) appointed Rosalind Wilson as its Chief Medical Officer (CMO), effective Saturday, according to a Thursday Australian bourse filing.
Its current CMO, Marissa Lim, has decided to move into semi-retirement.
Wilson was previously Chief Executive of Factor Therapeutics.
Its shares jumped 9% in recent trading on Thursday.